Our novel therapy for eliminating cancer tumors, MFA370, will be tested in clinical trials on metastatic bladder cancer. Preclinical studies have shown positive results in inducing cell death in breast, colorectal and prostate cancer cells too. MFA370 is planned to be a simple oral tablet with few if any side effects. It is a combination of two safe, standard, well-established pharmaceuticals that have already undergone large-scale clinical trials.
Company Details
- Employees
- 2
- Address
- Pepparedsleden 1, Mölndal,vastra Gotaland County Se-431 83,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.ectinresearch.com
- HQ
- Mölndal, Vastra Gotaland County
Ectin Research Questions
Ectin Research's website is https://www.ectinresearch.com
Ectin Research's LinkedIn profile is https://se.linkedin.com/company/ectin-research
Ectin Research has
2 employees.
View email and phone details for 2
employees at Ectin Research.
Ectin Research's industry is
Biotechnology Research
Ectin Research's top competitors are
Cereno Scientific,
Insingulo Ab,
Inicure Ab,
Oxcia Ab (Publ),
Irlab Therapeutics Ab,
Elicera Therapeutics Ab,
Brainzell,
Nanolyze,
Alzinova Ab,
Delta Life Science.
Ectin Research's categories are Biotechnology Research
